High-throughput high-content functional image analysis of neuronal proteins implicated in parkinson's disease

Neuromethods

Volumn 57, Issue , 2011, Pages 211-225

  Blaas, Eva ^a   Van Kesteren, Ronald E ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Cellular screening; High content analysis; Neurodegeneration; Parkinson's disease; SH SY5Y

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; SMALL INTERFERING RNA;

ARTICLE; CELL ASSAY; CELL VIABILITY; CELLULAR STRESS RESPONSE; DOPAMINERGIC NERVE CELL; FUNCTIONAL ASSESSMENT; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HIGH THROUGHPUT SCREENING; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEDICAL INSTRUMENTATION; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL;

EID: 79957728852     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-111-6_16     Document Type: Article

References (11)

1. Lees, A. J., Hardy, J., and Revesz, T. (2009) Parkinson's disease. Lancet 373, 2055-66.
2. Harrower, T. P., Michell, A. W., and Barker, R. A. (2005) Lewy bodies in parkinson's disease: Protectors or perpetrators? Exp Neurol 195, 1-6. (Pubitemid 41116808)
3. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl, S10-7.
4. Lee, F. J., and Liu, F. (2008) Genetic factors involved in the pathogenesis of parkinson's disease. Brain Res Rev 58, 354-64.
5. Abou-Sleiman, P. M., Muqit, M. M., and Wood, N. W. (2006) Expanding insights of mitochondrial dysfunction in parkinson's dis¬ease. Nat Rev Neurosci 7, 207-19. (Pubitemid 43292466)
6. Nicklas, W. J., Youngster, S. K., Kindt, M. V., and Heikkila, R. E. (1987) Mptp, mpp+ and mitochondrial function. Life Sci 40, 721-9.
7. Richardson, J. R., Caudle, W. M., Guillot, T. S., Watson, J. L., Nakamaru-Ogiso, E., Seo, B. B., Sherer, T. B., Greenamyre, J. T., Yagi, T., Matsuno-Yagi, A., and Miller, G. W. (2007) Obligatory role for complex i inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (mptp). Toxicol Sci 95, 196-204. (Pubitemid 44942790)
8. Fitzgerald, J. C., and Plun-Favreau, H. (2008) Emerging pathways in genetic parkinson's dis¬ease: Autosomal-recessive genes in parkinson's disease-a common pathway? FEBS J 275, 5758-66.
9. Bossers, K., Meerhoff, G., Balesar, R., van Dongen, J. W., Kruse, C. G., Swaab, D. F., and Verhaagen, J. (2009) Analysis of gene expression in parkinson's disease: Possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19, 91-107.
10. Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A., and Caldwell, G. A. (2008) Hypothesis-based rnai screening iden-tifes neuroprotective genes in a parkinson's disease model. Proc Natl Acad Sci USA 105, 728-33. (Pubitemid 351171776)
11. Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., and Sonntag, K. C. (2009) Gene expression profling of sub-stantia nigra dopamine neurons: Further insights into parkinson's disease pathology. Brain 132, 1795-809.